{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70000-0717",
      "marketing_end_date": "20270731",
      "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution",
      "labeler_name": "CARDINAL HEALTH",
      "brand_name": "Leader Olopatadine Hydrochloride Ophthalmic Solution",
      "active_ingredients": [
        {
          "name": "OLOPATADINE HYDROCHLORIDE",
          "strength": "1 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70000-0717-1",
          "description": "1 BOTTLE in 1 CARTON (70000-0717-1)  / 5 mL in 1 BOTTLE",
          "marketing_start_date": "20250415",
          "marketing_end_date": "20270731",
          "sample": false
        }
      ],
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "5b76eaf7-4541-a87c-e063-6294a90a8b47",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "OPHTHALMIC"
      ],
      "marketing_start_date": "20250415",
      "product_id": "70000-0717_5b76eaf7-4541-a87c-e063-6294a90a8b47",
      "application_number": "ANDA206046",
      "brand_name_base": "Leader Olopatadine Hydrochloride Ophthalmic Solution",
      "pharm_class": [
        "Decreased Histamine Release [PE]",
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]",
        "Histamine-1 Receptor Inhibitor [EPC]",
        "Mast Cell Stabilizer [EPC]"
      ]
    }
  ]
}